Frankfurt - Delayed Quote EUR
Heron Therapeutics, Inc. (AXD2.F)
1.9010
+0.0260
+(1.39%)
As of 8:04:42 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-22,529
-22,529
-58,789
-146,912
-203,354
Investing Cash Flow
18,714
18,714
17,995
-3,324
32,729
Financing Cash Flow
940
940
54,107
75,059
156,028
End Cash Position
25,802
25,802
28,677
15,364
90,541
Interest Paid Supplemental Data
4,860
4,860
3,059
2,250
1,244
Capital Expenditure
-1,706
-1,706
-1,545
-1,825
-3,022
Issuance of Capital Stock
--
--
29,755
75,145
--
Issuance of Debt
--
--
24,350
--
148,963
Free Cash Flow
-24,235
-24,235
-60,334
-148,737
-206,376
12/31/2021 - 5/31/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
12X1.F Anavex Life Sciences Corp.
8.05
-0.96%
HTD.SG Corcept Therapeutics Inc
60.20
-2.53%
M8W.F MediWound Ltd.
15.60
+0.65%
RXK3.F SELLAS Life Sciences Group, Inc.
1.1500
-2.21%
REGN34.SA Regeneron Pharmaceuticals, Inc.
55.72
0.00%
REGN.VI Regeneron Pharmaceuticals, Inc.
515.60
-0.81%
PYPD PolyPid Ltd.
2.7500
+0.36%
BVNRY Bavarian Nordic A/S
7.72
0.00%
SNGX Soligenix, Inc.
2.0700
+0.49%
XFOR X4 Pharmaceuticals, Inc.
0.2013
-0.84%